Здоровье

Emergent BioSolutions said Monday that Johnson & Johnson has agreed to pay $50 million to settle claims related to a terminated COVID-19 vaccine deal. The

Purdue Pharma creditors on Monday asked the U.S. Bankruptcy Court for permission to sue the company’s wealthy owners, arguing that litigation could serve as both

Danish drugmaker Novo Nordisk has been reprimanded by British regulators for failing to disclose fees and expenses paid to healthcare professionals and healthcare organisations in

Eli Lilly to acquire Morphic Holding companies said Monday that for $3.2 billion in cash, they will give the U.S. drugmaker access to an experimental

South Korea said it would abandon a plan to suspend the licences of striking trainee doctors, offering a concession to end a months-long strike sparked

Roche will halt a trial of a new immunotherapy for lung cancer after the drug failed to show benefits over Merck & Co’s established treatment

Germany has reported a rare outbreak of highly pathogenic H7N5 bird flu on a farm in the western part of the country. The outbreak killed

Type 2 diabetes patients taking GTP-1 drugs, including Ozempic, have a lower risk of developing 10 obesity-related cancers than those taking insulin and other diabetes

British drugmaker GSK on Wednesday bought out partner CureVac from its alliance to develop influenza vaccines and COVID-19, boosting its expertise in informatics RNA and

Colorado health officials announced Wednesday that an adult man has tested positive for bird flu after reporting mild symptoms including conjunctivitis. Officials said the man